IL191523A0 - Lansoprazole orally disintegrating tablets - Google Patents

Lansoprazole orally disintegrating tablets

Info

Publication number
IL191523A0
IL191523A0 IL191523A IL19152308A IL191523A0 IL 191523 A0 IL191523 A0 IL 191523A0 IL 191523 A IL191523 A IL 191523A IL 19152308 A IL19152308 A IL 19152308A IL 191523 A0 IL191523 A0 IL 191523A0
Authority
IL
Israel
Prior art keywords
orally disintegrating
disintegrating tablets
lansoprazole
lansoprazole orally
tablets
Prior art date
Application number
IL191523A
Other languages
English (en)
Original Assignee
Teva Pharma
Silver David
Ari Pardo Limor
Antler Sivan
Shterman Nava
Capuan Simona Di
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Silver David, Ari Pardo Limor, Antler Sivan, Shterman Nava, Capuan Simona Di filed Critical Teva Pharma
Publication of IL191523A0 publication Critical patent/IL191523A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL191523A 2005-12-20 2008-05-18 Lansoprazole orally disintegrating tablets IL191523A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/046296 WO2007078271A2 (en) 2005-12-20 2005-12-20 Lansoprazole orally disintegrating tablets

Publications (1)

Publication Number Publication Date
IL191523A0 true IL191523A0 (en) 2008-12-29

Family

ID=37672393

Family Applications (1)

Application Number Title Priority Date Filing Date
IL191523A IL191523A0 (en) 2005-12-20 2008-05-18 Lansoprazole orally disintegrating tablets

Country Status (5)

Country Link
JP (1) JP2009519334A (ja)
CN (1) CN101340897A (ja)
CA (1) CA2630235A1 (ja)
IL (1) IL191523A0 (ja)
WO (1) WO2007078271A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
TWI441658B (zh) 2008-03-11 2014-06-21 Takeda Pharmaceutical 口腔崩解固體製劑
CN101507718B (zh) * 2009-03-03 2011-05-04 张登科 雷贝拉唑钠肠溶口崩片及其制备方法
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
KR20140007364A (ko) * 2010-12-27 2014-01-17 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴정
CN102805737A (zh) * 2012-09-03 2012-12-05 海南中化联合制药工业股份有限公司 一种兰索拉唑肠溶口崩片及其制备方法
CN105392486A (zh) * 2013-05-21 2016-03-09 武田药品工业株式会社 口腔崩解片
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
ES2274625T3 (es) * 1998-05-18 2007-05-16 Takeda Pharmaceutical Company Limited Comprimidos desintegrables en la boca que comprenden un bencimidazol.
EP1594479A1 (en) * 2003-01-31 2005-11-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and processes for their preparation
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2005046634A2 (de) * 2003-11-14 2005-05-26 Siegfried Generics International Ag Magensaftresistente verabreichungsform
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture

Also Published As

Publication number Publication date
JP2009519334A (ja) 2009-05-14
CA2630235A1 (en) 2007-07-12
CN101340897A (zh) 2009-01-07
WO2007078271A3 (en) 2007-10-11
WO2007078271A2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
IL194355A0 (en) Orally disintegrating tablets
EP2098250A4 (en) ORAL CRACKING SOLID PREPARATION
EP2218443A4 (en) COMPRESSED ORALLY DISINTEGRATING
IL191523A0 (en) Lansoprazole orally disintegrating tablets
EP1923074A4 (en) TABLET WHICH CAN BE ORALLY DISINTEGRATED
HK1155978A1 (en) Orally disintegrating tablets
GB2427420B (en) Packer
EP1951203A4 (en) COMPRESSED QUICKLY DISINTEGRATION ORALLY
EP1948543A4 (en) DISPENSER OF TABLETS
EP1905430A4 (en) TABLET
IL190397A0 (en) Dispersible tablets comprising deferasirox
GB2429473B (en) Packer
AP2008004533A0 (en) Pharmaceutical combination
EP2133096A4 (en) IN THE MOUTHING TABLET
EP1961413A4 (en) RAPID DISINTEGRATION ORAL TABLET
IL191923A0 (en) Lansoprazole orally disintegrating tablets
SI2040684T1 (sl) Večenotne tablete
IL177830A0 (en) Disintegrating tablets comprising licarbazepine
GB0504176D0 (en) Anti-tamper devices
GB0424323D0 (en) Tablet
ZA200804666B (en) Pharmaceutical combination
GB0515267D0 (en) Packer
EP1867324A4 (en) COMPRESSED
AP2006003752A0 (en) Rapidly disintegrating taste-masked tablet
EP1859791A4 (en) SUGAR-COATED PILL